Optical biosensors are nanomaterially categorized as fluorescent biosensors, colorimetric biosensors, localized surface plasmon resonance (LSPR) sensors are mainly developed to quantify non-Aβ-Tau biomarkers for the monitoring of AD. This evidence concerns the gene MAPT and Alzheimer disease.